Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

POLE3 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement POLE3 dans IF, ELISA et FACS. Il présente une réactivité avec des échantillons de Humain.
N° du produit ABIN7126802
639,45 €
Plus frais de livraison 40,00 € et TVA
100 μg
Destination: France
Envoi sous 6 à 10 jours ouvrables

Aperçu rapide pour POLE3 anticorps (ABIN7126802)

Antigène

Voir toutes POLE3 Anticorps
POLE3 (Polymerase (DNA Directed), epsilon 3 (p17 Subunit) (POLE3))

Reactivité

  • 42
  • 19
  • 15
  • 5
  • 5
  • 5
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 35
  • 7
Souris

Clonalité

  • 38
  • 4
Monoclonal

Conjugué

  • 28
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp POLE3 est non-conjugé

Application

  • 24
  • 11
  • 7
  • 6
  • 6
  • 4
  • 2
  • 2
  • 1
  • 1
Immunofluorescence (IF), ELISA, Flow Cytometry (FACS)

Clone

PCRP-POLE3-3D3
  • Fonction

    POLE3 / CHRAC17 Antibody

    Specificité

    DNA replication is initiated by the binding of initiation factors to the origin of replication. Nucleosomes inhibit access to the replication machinery at these origin sequences. Nucleosome remodeling factors increase the accessibility of nucleosomal DNA to transcriptional regulators. CHRAC15 and CHRAC17 are subunits of the nucleosomal remodeling factor CHRAC (chromatin accessibility complex), which increases the accessibility of nucleosomal DNA in an ATP-dependent manner. Unlike other known chromatin remodeling factors, CHRAC also functions during chromatin assembly by using ATP to convert irregular chromatin into a regular array of nucleosomes with even spacing. This conversion process occurs when CHRAC organizes randomly deposited histones into a regularly spaced array. In the presence of CHRAC, the nucleosomal ATPase ISWI catalyzes several ATP-dependent transitions of chromatin structure.

    Réactivité croisée (Details)

    Human. Predicted to react in Mouse, Rat and Xenopus.

    Purification

    200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.

    Immunogène

    Recombinant full-length human POLE3 protein

    Isotype

    IgG2a
  • Indications d'application

    Known_Application: ELISA (For coating, order antibody without BSA), Flow Cytometry (1-2 μg/million cells),Immunoprecipitation (1-2 μg per 100-500 μg of total protein (1 mL of cell lysate)), ,Immunofluorescence (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or K562 cells.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10  mM PBS

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody with azide - store at 2 to 8 °C. Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.

    Date de péremption

    24 months
  • Antigène

    POLE3 (Polymerase (DNA Directed), epsilon 3 (p17 Subunit) (POLE3))

    Autre désignation

    POLE3

    Sujet

    Arsenic transactivated protein, ASTP, CHRAC17, Chromatin accessibility complex 17 kDa protein, DNA polymerase II subunit 3, Histone fold protein CHRAC17, HuCHRAC17, Polymerase (DNA directed) epsilon 3 (POLE3), YBL1

    HeLa or K562 cells.

    Poids moléculaire

    16.86kDa

    ID gène

    54107, 108112

    UniProt

    Q9NRF9

    Pathways

    Réparation de l'ADN
Vous êtes ici:
Chat with us!